In this IgNS 2024 conference video, Dr. Eleni Tiniakou, a rheumatologist and assistant professor at Johns Hopkins, shares advancements in myositis treatment approaches. She highlights evidence-based therapies, including interferon pathway inhibitors, B-cell targeting, and early research on CAR T-cell applications. Dr. Tiniakou emphasizes the importance of personalized approaches to address the diverse pathogenic factors in myositis treatment. These insights provide physicians tools to better tailor treatments across myositis subtypes and improve patient outcomes.

The American Heart Association (AHA) will be hosting its annual scientific sessions at the McCormick Place Convention Center in Chicago from Nov. 16 to 18, 2024. This conference will focus on the latest innovations for scientists, clinicians, researchers, and other health care professionals interested in cardiovascular disease.

We will be covering the event for you, so stay tuned for reports with highlights and a wrap-up of the conference. Click above to access some of the highlights that caught our attention.